Plainview saw at least $3,569 in Medicaid spending for COVID-19 services in 2024

In Plainview, Medicaid disbursements for services billed under HCPCS codes specifically tied to COVID-19 reached at least $3,569 during 2024, according to the U.S. Department of Health and Human Services Medicaid Provider Spending database.

Medicaid, administered by individual states and funded through both federal and state contributions, offers health coverage to low-income individuals, families, seniors, children, and disabled individuals, making it a significant component of U.S. health care.

Because taxpayers fund Medicaid, shifts in local billing reflect community-level allocation of public health care funds.

The analysis identified COVID-19–related services based on HCPCS codes classified as “COVID-19” or “coronavirus”-related within billing descriptions or supporting data. These totals capture only those services directly labeled as COVID-related, potentially excluding some pandemic-related care billed under less specific codes.

For context, Brooklyn recorded the highest amount of Medicaid payments tied to COVID-19 services in New York for 2024, totaling $3,718,101 in claims related to the virus.

Data indicates Acupath Laboratories, Inc was the sole provider submitting Medicaid claims for COVID-19–related services in Plainview in 2024.

During the pandemic, services specific to COVID-19 contributed to a notable rise in Medicaid spending in the city.

Average yearly Medicaid payments in Plainview during the two years prior to the pandemic were $8,298,842.

According to the Centers for Medicare & Medicaid Services, combined state and federal Medicaid spending reached $871.7 billion in fiscal year 2023, making up about 18% of all national health expenditures, rising substantially from $613.5 billion in 2019, before the COVID-19 pandemic.

This increase, of about 40% over several years, was largely due to increased enrollment and higher service use during and following the pandemic.

Recent federal budget measures under the Trump administration have featured major proposals to scale down federal Medicaid funding and make changes to the program. The “One Big Beautiful Bill Act,” signed into law in 2025, is expected to reduce federal Medicaid spending by more than $1 trillion over the next 10 years. It also adds work requirements and increased cost-sharing, which could lower coverage and funding for certain groups. These measures are anticipated to put more financial responsibility on states and limit the expansion of federal Medicaid support, even as the program continues to serve tens of millions nationwide.

Note: Includes only HCPCS codes specifically labeled for COVID-19 services; totals do not account for all pandemic-related health spending.

The information in this article is based on data from the U.S. Department of Health and Human Services Medicaid Provider Spending database. The original data is available here.